<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-28W56P12</identifier><date>1994</date><creator>Štabuc, Borut</creator><relation>documents/doc/2/URN_NBN_SI_doc-28W56P12_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-28W56P12_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 41-50</format><identifier identifier_type="COBISSID_HOST">118745</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-28W56P12</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Rak na črevesju</source><rights>InC</rights><subject language_type_id="slv">Colonic neoplasms</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">Fluorouracil</subject><subject language_type_id="slv">Human</subject><subject language_type_id="slv">Leucovorin</subject><subject language_type_id="slv">Levamisole</subject><subject language_type_id="slv">Neoplasm metastasis</subject><subject language_type_id="slv">Perfusion, regional</subject><subject language_type_id="slv">Rectal neoplasms</subject><title>Sistemsko zdravljenje raka debelega črevesa in danke</title></Record>